Pathologic response rates to neoadjuvant pembrolizumab in locally advanced (LA) resectable cutaneous squamous cell carcinoma (cSCC)

被引：0
|
作者：
Amatore, Florent
Sridharan, Shaum
Karunamurthy, Arivarasan
Wang, Hong
Patel, Ravi
Pugliano-Mauro, Melissa
Kim, Seungwon
Choudry, Mohammad Haroon Asif
Pingpank, James F., Jr.
Holtzman, Matthew Peter
Duvvuri, Uma Maheswari
Ferris, Robert L.
Luke, Jason J.
Kirkwood, John M.
Najjar, Yana G.
Pullara, Filippo
Chennubhotla, Chakra
Zarour, Hassane M.
Davar, Diwakar
机构：
[1] UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[2] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA
[3] Univ Pittsburgh Med Ctr UPMC, Pittsburgh, PA USA
[4] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA
[5] Univ Pittsburgh, Pittsburgh, PA USA
[6] Univ Pittsburgh Med Ctr UPMC, Dept Dermatol, Pittsburgh, PA USA
[7] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[8] UPMC Hlth Syst, Pittsburgh, PA USA
[9] UPMC HIllman Canc Ctr, Pittsburgh, PA USA
[10] Predxbio, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9591
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase 2 study of de-escalation in resectable, locally advanced cutaneous squamous cell carcinoma (cSCC) with the use of neoadjuvant pembrolizumab: DeSquamate
    Ladwa, Rahul
    Lee, Jenny H. J.
    Porceddu, Sandro V.
    McGrath, Margaret Louise
    Cooper, Caroline
    Liu, Howard
    Gupta, Ruta
    Cuscaden, Claire
    Nottage, Michelle K.
    Clark, Jonathan
    Le, Dieu
    Pauley, Marketa
    Gonzalez-Cruz, Jazmina
    Frazer, Ian
    Hughes, Brett Gordon Maxwell
    Panizza, Benedict J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
    Yang, Yalan
    Xin, Dao
    Wang, Huike
    Guan, Lulu
    Meng, Xiangrui
    Lu, Taiying
    Bai, Xiwen
    Wang, Feng
    [J]. JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 1443 - 1455
  • [3] Therapy with Cemiplimab for locally advanced cutaneous Squamous Cell Carcinoma (cSCC)
    Reschke, R.
    Simon, J. C.
    Kage, P.
    Ziemer, M.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 41 - 42
  • [4] Pembrolizumab as monotherapy in locally advanced cutaneous squamous cell carcinoma
    Giri, Anshu
    Bauman, Jessica R.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (10) : 1029 - 1038
  • [5] Major response to pembrolizumab in two patients with locally advanced cutaneous squamous cell carcinoma
    Degache, E.
    Crochet, J.
    Simon, N.
    Tardieu, M.
    Trabelsi, S.
    Moncourier, M.
    Templier, I.
    Foroni, L.
    Lemoigne, A.
    Pinel, N.
    Gil, H.
    Bouillet, L.
    Leccia, M. T.
    Charles, J.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (07) : E257 - E258
  • [6] Neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV negative head and neck squamous cell carcinoma (HNSCC).
    Uppaluri, Ravindra
    Zolkind, Paul
    Lin, Tianxiang
    Nussenbaum, Brian
    Jackson, Ryan S.
    Rich, Jason
    Pipkorn, Patrik
    Paniello, Randal
    Thorstad, Wade
    Michel, Loren
    Mudianto, Tenny
    Oppelt, Peter John
    Wildes, Tanya Marya
    Dunn, Gavin P.
    Piccirillo, Jay F.
    Kallogjeri, Donna
    Rodig, Scott
    Hagemann, Ian S.
    Chernock, Rebecca
    Adkins, Douglas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Enhanced pathologic tumor response with two cycles of neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV-negative head and neck squamous cell carcinoma (HNSCC).
    Uppaluri, Ravindra
    Chernock, Rebecca
    Mansour, Mena
    Jackson, Ryan
    Rich, Jason
    Pipkorn, Patrik
    Paniello, Randal C.
    Puram, Sidharth
    Zevallos, Jose P.
    Annino, Donald J.
    Goguen, Laura A.
    Morris, Luc
    Haddad, Robert I.
    Hanna, Glenn J.
    Oppelt, Peter John
    Dunn, Lara
    Ley, Jessica C.
    Kallogjeri, Dorina
    Egloff, Ann Marie
    Adkins, Douglas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] The KEYNOTE-630 Trial: A Phase 3 Study of Adjuvant Pembrolizumab in High -Risk Locally Advanced (LA) Cutaneous Squamous Cell Carcinoma (cSCC)
    Schenker, M.
    Klochikhin, M.
    Kirtbaya, D.
    Mother, L.
    Gschnell, M.
    Robert, C.
    Meyer, N.
    Flatz, L.
    Dalle, S.
    Beylot-Barry, M.
    Eigentler, T.
    Silverman, R. Kloss
    Gumuscu, B.
    Yuan, J.
    Bratland, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E81 - E82
  • [9] Preoperative prediction of pathologic response to neoadjuvant immunotherapy in resectable locally advanced head and neck squamous cell carcinoma using multiparametric MRI
    Han, Jiayue
    Wei, Yuhan
    Tao, Yuxi
    Luo, Lianmei
    Cheng, Ci
    Zhang, Yaqin
    [J]. CHINESE JOURNAL OF ACADEMIC RADIOLOGY, 2024,
  • [10] Neoadjuvant pembrolizumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Interim results.
    Wang, Weiwei
    Li, Li
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16011 - E16011
12345